"Our goal is that seriously ill patients are treated in the best possible way," said Hermann Groehe, who will present draft legislation to the German cabinet tomorrow.
The draft bill comes as many parts of the world are relaxing laws on cannabis use and medicinal marijuana is gaining popularity to ease suffering from cancer, glaucoma, HIV or AIDS, Hepatitis C, Parkinson's disease and other serious conditions.
However, the issue of recreational and medical cannabis use is controversial in many countries, as opponents fear crime connected to drug abuse and addiction. Some argue pot use could lead to dependence on harder drugs.
Until specially supervised plantations have been established to grow cannabis, Germany will import "medical marijuana", the minister added.
"Without wishing to pre-judge the work of the Bundestag (lower house of parliament), it is likely that the law will come into force in the spring of 2017," Groehe told German daily Die Welt.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
